Viewing StudyNCT00105469



Ignite Creation Date: 2024-05-05 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00105469
Status: COMPLETED
Last Update Posted: 2013-12-16
First Post: 2005-03-14

Brief Title: Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis C-01-401-004
Sponsor:
Organization: Merck Sharp Dohme LLC

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 743
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: